Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease
Year: 2017
Type: article
Source: Kidney International Supplements
Authors: Michelle J. Pena, Peter Stenvinkel, Matthias Kretzler, Dwomoa Adu, Sanjay Kumar Agarwal, Josef Coresh, Harold I. Feldman, Agnes B. Fogo, Ron T. Gansevoort, David C. Harris, Vivekanand Jha, Zhi-Hong Liu, Valerie A. Luyckx, Ziad A. Massy, Ravindra Mehta, Robert G. Nelson, Donal J. O'Donoghue, Gregorio T. Obrador, Charlotte J. Roberts, Laura Sola, Ernest K. Sumaili, Sajja Tatiyanupanwong, Bernadette Thomas, Andrzej Wiecek, Chirag R. Parikh, Hiddo J.L. Heerspink
Institutions: University Medical Center Groningen, University of Groningen, Karolinska Institutet, University of Michigan, Michigan Medicine, University of Ghana, All India Institute of Medical Sciences, Johns Hopkins University, University of Pennsylvania, Vanderbilt University, Vanderbilt University Medical Center, The University of Sydney, Westmead Institute for Medical Research, University of Oxford, George Institute for Global Health, Nanjing General Hospital of Nanjing Military Command, Nanjing University, University of Zurich, University Hospital Zurich, Inserm, Université de Versailles Saint-Quentin-en-Yvelines, Centre de recherche en Epidémiologie et Santé des Populations, Hôpital Ambroise-Paré, University of California San Diego, National Institute of Diabetes and Digestive and Kidney Diseases, National Health Service, Salford Royal NHS Foundation Trust, University of Manchester, Universidad Panamericana, campus Ciudad de México, Universidad Panamericana, Ministerio de Salud Pública, University of Kinshasa, Khon Kaen University, University of Washington, Medical University of Silesia, Yale University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Teva Pharmaceutical Industries, CSL Behring, International Society of Nephrology, Fresenius Medical Care North America, Astellas Pharma, Grifols, Akebia Therapeutics, National Institutes of Health, Merck Sharp and Dohme, Relypsa, National Institute of Diabetes and Digestive and Kidney Diseases
OpenAlex ID: W2755793078